$MOH
MOLINA HEALTHCARE, INC. Stock $moh

$moh Overview Financials Valuation SEC Filings Company Website

2013 Q4 Form 10-K Financial Statement

#000117992914000004 Filed on February 26, 2014

Income Statement

Concept	2013 Q4	2012 Q4	2012 Q3
Revenue	$1.706B	$1.578B	$1.540B
YoY Change	8.09%	20.79%	30.88%
Cost Of Revenue	$1.457B	$1.319B	$1.357B
YoY Change	10.45%	22.46%	36.56%
Gross Profit	$249.0M	$259.1M	$183.2M
YoY Change	-3.9%	12.9%	0.11%
Gross Profit Margin	14.6%	16.42%	11.89%
Selling, General & Admin	$231.4M	$191.1M	$164.9M
YoY Change	21.09%	13.14%	21.25%
% of Gross Profit	92.93%	73.76%	90.01%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$25.90M	$20.50M	$20.28M
YoY Change	26.34%	-6.82%	13.85%
% of Gross Profit	10.4%	7.91%	11.07%
Operating Expenses	$251.7M	$207.3M	$180.8M
YoY Change	21.42%	14.53%	20.94%
Operating Profit	-$2.700M	$54.13M	$2.368M
YoY Change	-104.99%	-436.17%	-92.95%
Interest Expense	-$13.80M	-$4.300M	$4.315M
YoY Change	220.93%	10.26%	-1.48%
% of Operating Profit		-7.94%	182.22%
Other Income/Expense, Net	$0.00	$300.0K	-$4.499M
YoY Change	-100.0%
Pretax Income	-$16.50M	$50.15M	-$2.131M
YoY Change	-132.9%	-351.28%	-107.3%
Income Tax	-$7.500M	$21.60M	-$1.966M
% Of Pretax Income		43.07%
Net Earnings	-$9.126M	$25.64M	$3.364M
YoY Change	-135.59%	-177.8%	-82.25%
Net Earnings / Revenue	-0.54%	1.63%	0.22%
Basic Earnings Per Share	-$0.20	$0.55	$0.07
Diluted Earnings Per Share	-$0.20	$0.54	$0.07
COMMON SHARES
Basic Shares Outstanding	45.76M shares	46.58M shares	46.55M shares
Diluted Shares Outstanding			46.88M shares

Balance Sheet

Concept	2013 Q4	2012 Q4	2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.639B	$1.139B	$1.072B
YoY Change	43.94%	37.07%	32.0%
Cash & Equivalents	$936.0M	$796.0M	$715.5M
Short-Term Investments	$703.1M	$342.8M	$356.9M
Other Short-Term Assets	$42.48M	$28.39M	$30.00M
YoY Change	49.67%	46.06%	-17.58%
Inventory
Prepaid Expenses
Receivables	$298.9M	$149.7M	$156.9M
Other Receivables	$32.80M	$0.00	$33.50M
Total Short-Term Assets	$2.040B	$1.349B	$1.314B
YoY Change	51.18%	28.72%	27.04%
LONG-TERM ASSETS
Property, Plant & Equipment	$292.1M	$221.4M	$211.0M
YoY Change	31.9%	15.98%	65.21%
Goodwill	$230.7M	$151.1M	$151.1M
YoY Change	52.72%	-1.86%
Intangibles
YoY Change
Long-Term Investments	$10.90M	$13.40M	$13.50M
YoY Change	-18.66%	243.59%	-25.41%
Other Assets	$46.46M	$19.62M	$20.10M
YoY Change	136.8%	14.75%	-82.87%
Total Long-Term Assets	$948.3M	$585.7M	$592.7M
YoY Change	61.92%	-3.04%	1.54%
TOTAL ASSETS
Total Short-Term Assets	$2.040B	$1.349B	$1.314B
Total Long-Term Assets	$948.3M	$585.7M	$592.7M
Total Assets	$2.988B	$1.935B	$1.907B
YoY Change	54.43%	17.11%	17.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$320.0M	$184.0M	$151.0M
YoY Change	73.91%	25.0%	6.56%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$182.0M	$1.155M	$1.143M
YoY Change	15658.27%	-3.51%
Total Short-Term Liabilities	$1.294B	$828.0M	$831.9M
YoY Change	56.27%	37.59%	37.65%
LONG-TERM LIABILITIES
Long-Term Debt	$602.9M	$261.8M	$260.6M
YoY Change	130.3%	20.68%	55.0%
Other Long-Term Liabilities	$26.35M	$23.48M	$22.10M
YoY Change	12.23%	7.8%	-46.1%
Total Long-Term Liabilities	$26.35M	$285.3M	$282.7M
YoY Change	-90.76%	19.5%	35.18%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.294B	$828.0M	$831.9M
Total Long-Term Liabilities	$26.35M	$285.3M	$282.7M
Total Liabilities	$2.110B	$1.153B	$1.152B
YoY Change	83.08%	28.47%	37.72%
SHAREHOLDERS EQUITY
Retained Earnings	$553.1M	$500.2M	$474.6M
YoY Change	10.58%	2.0%
Common Stock	$340.8M	$285.5M	$280.7M
YoY Change	19.38%	7.33%	7.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$0.00	$3.000M
YoY Change	-100.0%
Treasury Stock Shares		111.0K shares
Shareholders Equity	$892.9M	$782.3M	$755.0M
YoY Change
Total Liabilities & Shareholders Equity	$3.003B	$1.935B	$1.907B
YoY Change	55.2%	17.11%	17.84%

Cashflow Statement

Concept	2013 Q4	2012 Q4	2012 Q3
OPERATING ACTIVITIES
Net Income	-$9.126M	$25.64M	$3.364M
YoY Change	-135.59%	-177.8%	-82.25%
Depreciation, Depletion And Amortization	$25.90M	$20.50M	$20.28M
YoY Change	26.34%	-6.82%	13.85%
Cash From Operating Activities	$78.40M	$83.80M	$28.00M
YoY Change	-6.44%	19.37%	-30.52%
INVESTING ACTIVITIES
Capital Expenditures	-$33.60M	-$25.60M	-$19.20M
YoY Change	31.25%	74.15%	28.0%
Acquisitions
YoY Change
Other Investing Activities	$31.70M	$22.80M	-$10.20M
YoY Change	39.04%	-122.89%	-191.07%
Cash From Investing Activities	-$1.900M	-$2.800M	-$29.50M
YoY Change	-32.14%	-97.55%	656.41%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.900M	-700.0K	-10.20M
YoY Change	-514.29%	-101.39%	25.93%
NET CHANGE
Cash From Operating Activities	78.40M	83.80M	28.00M
Cash From Investing Activities	-1.900M	-2.800M	-29.50M
Cash From Financing Activities	2.900M	-700.0K	-10.20M
Net Change In Cash	79.40M	80.30M	-11.70M
YoY Change	-1.12%	1154.69%	-141.34%
FREE CASH FLOW
Cash From Operating Activities	$78.40M	$83.80M	$28.00M
Capital Expenditures	-$33.60M	-$25.60M	-$19.20M
Free Cash Flow	$112.0M	$109.4M	$47.20M
YoY Change	2.38%	28.86%	-14.65%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	319965000	USD
CY2012Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	184034000	USD
CY2012Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	6520000	USD
CY2013Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	171057000	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	207934000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1086000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-457000	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	340848000	USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	285524000	USD
CY2011	us-gaap	Adjustment For Amortization AdjustmentForAmortization	30200000	USD
CY2013	us-gaap	Adjustment For Amortization AdjustmentForAmortization	46400000	USD
CY2012	us-gaap	Adjustment For Amortization AdjustmentForAmortization	36200000	USD
CY2012	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	3100000	USD
CY2011	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	900000	USD
CY2013	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	1600000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	79000000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	32000000	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	19500000	USD
CY2011	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	937000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	1602000	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	3141000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	78997000	USD
CY2012	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	20018000	USD
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	28694000	USD
CY2011	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	17052000	USD
CY2011	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	10658000	USD
CY2012	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	14556000	USD
CY2013	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	24501000	USD
CY2011	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5512000	USD
CY2012	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5942000	USD
CY2013	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	22103000	USD
CY2012	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1089000	USD
CY2013	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3692000	USD
CY2011	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2818000	USD
CY2011	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17450000	USD
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17906000	USD
CY2012	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	20176000	USD
CY2013Q4	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	608000000	USD
CY2012Q4	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	550000000	USD
CY2013Q4	us-gaap	Assets Assets	3002937000	USD
CY2012Q4	us-gaap	Assets Assets	1934822000	USD
CY2011Q4	us-gaap	Assets Assets	1652146000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	2039664000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	1349126000	USD
CY2008Q1	us-gaap	Auction Rate Securities Noncurrent AuctionRateSecuritiesNoncurrent	82100000	USD
CY2012Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	357000000	USD
CY2013Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	715702000	USD
CY2012Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	356264000	USD
CY2013Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	713950000	USD
CY2012Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	89195000	USD
CY2013Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	306531000	USD
CY2012Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	13419000	USD
CY2013Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	44529000	USD
CY2013Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	353814000	USD
CY2013Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	352447000	USD
CY2013Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	11400000	USD
CY2013Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	10898000	USD
CY2013Q4	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	715702000	USD
CY2013Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	350488000	USD
CY2013Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	350605000	USD
CY2013Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	713950000	USD
CY2013	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	0	USD
CY2012	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	0	USD
CY2011	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	1676000	USD
CY2012	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2013	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2400000	USD
CY2011	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2013Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	159394000	USD
CY2012Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	0	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Receivable CapitalLeasesFutureMinimumPaymentsReceivable	21999000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Receivable Current CapitalLeasesFutureMinimumPaymentsReceivableCurrent	4192000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Receivable Due Thereafter CapitalLeasesFutureMinimumPaymentsReceivableDueThereafter	2832000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Receivable In Five Years CapitalLeasesFutureMinimumPaymentsReceivableInFiveYears	3581000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Receivable In Four Years CapitalLeasesFutureMinimumPaymentsReceivableInFourYears	3742000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Receivable In Three Years CapitalLeasesFutureMinimumPaymentsReceivableInThreeYears	3542000	USD
CY2013Q4	us-gaap	Capital Leases Future Minimum Payments Receivable In Two Years CapitalLeasesFutureMinimumPaymentsReceivableInTwoYears	4110000	USD
CY2013Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	104016000	USD
CY2012Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	86901000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	795770000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	935895000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	455886000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	493827000	USD
CY2011	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	37941000	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	301943000	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	140125000	USD
CY2013Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	53.8475
CY2013Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	53.8475
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2013Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2013Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46762000	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	45871000	shares
CY2013Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	46000	USD
CY2012Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	47000	USD
CY2011	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	21605000	USD
CY2012	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	10738000	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	52300000	USD
CY2013	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	27211000	USD
CY2011	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	0	USD
CY2012	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	0	USD
CY2013Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	416368000	USD
CY2012Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	175468000	USD
CY2013	us-gaap	Cost Of Goods Sold Depreciation And Amortization CostOfGoodsSoldDepreciationAndAmortization	93866000	USD
CY2011	us-gaap	Cost Of Goods Sold Depreciation And Amortization CostOfGoodsSoldDepreciationAndAmortization	74383000	USD
CY2012	us-gaap	Cost Of Goods Sold Depreciation And Amortization CostOfGoodsSoldDepreciationAndAmortization	78764000	USD
CY2011	us-gaap	Cost Of Services Amortization CostOfServicesAmortization	6822000	USD
CY2012	us-gaap	Cost Of Services Amortization CostOfServicesAmortization	1571000	USD
CY2013	us-gaap	Cost Of Services Amortization CostOfServicesAmortization	2914000	USD
CY2012	us-gaap	Costs And Expenses CostsAndExpenses	5873116000	USD
CY2011	us-gaap	Costs And Expenses CostsAndExpenses	4404442000	USD
CY2013	us-gaap	Costs And Expenses CostsAndExpenses	6452374000	USD
CY2013Q4	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear	45675000	USD
CY2012Q4	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear	58313000	USD
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	66883000	USD
CY2012	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	23019000	USD
CY2011	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	24435000	USD
CY2012	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	24273000	USD
CY2011	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	26022000	USD
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	67464000	USD
CY2013	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	581000	USD
CY2012	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1254000	USD
CY2011	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1587000	USD
CY2013Q1	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	13490236	shares
CY2013	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	13490236	shares
CY2013Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	598240000	USD
CY2013Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	737000000	USD
CY2013Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	138760000	USD
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-25498000	USD
CY2012	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-9205000	USD
CY2011	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	16905000	USD
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-31148000	USD
CY2012	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-13760000	USD
CY2011	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	16892000	USD
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	141798000	USD
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	122216000	USD
CY2013	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-5650000	USD
CY2012	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-4555000	USD
CY2011	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-13000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	-5457000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	25976000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	32443000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	26556000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	27000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	27000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	176000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-928000	USD
CY2013Q4	us-gaap	Deferred Tax Assets State Taxes DeferredTaxAssetsStateTaxes	-1323000	USD
CY2012Q4	us-gaap	Deferred Tax Assets State Taxes DeferredTaxAssetsStateTaxes	-606000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	2540000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	2518000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	2087000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	1611000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	19545000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	15381000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	2936000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	1712000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Unearned Premiums Reserve DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve	15675000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Unearned Premiums Reserve DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve	10543000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	380000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	-283000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3600000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3000000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance Current DeferredTaxAssetsValuationAllowanceCurrent	602000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance Current DeferredTaxAssetsValuationAllowanceCurrent	511000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance Noncurrent DeferredTaxAssetsValuationAllowanceNoncurrent	3084000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance Noncurrent DeferredTaxAssetsValuationAllowanceNoncurrent	2383000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	5410000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	-466000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	-27543000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	0	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	37900000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	580000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	24000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	-702000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	40433000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	44198000	USD
CY2012	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	10700000	USD
CY2013	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	12800000	USD
CY2011	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	8500000	USD
CY2013	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.04
CY2012	us-gaap	Depreciation Depreciation	20500000	USD
CY2011	us-gaap	Depreciation Depreciation	17500000	USD
CY2013	us-gaap	Depreciation Depreciation	26600000	USD
CY2012	us-gaap	Depreciation And Amortization DepreciationAndAmortization	63114000	USD
CY2013	us-gaap	Depreciation And Amortization DepreciationAndAmortization	72743000	USD
CY2011	us-gaap	Depreciation And Amortization DepreciationAndAmortization	48253000	USD
CY2011	us-gaap	Depreciation And Amortization Discontinued Operations DepreciationAndAmortizationDiscontinuedOperations	2437000	USD
CY2012	us-gaap	Depreciation And Amortization Discontinued Operations DepreciationAndAmortizationDiscontinuedOperations	590000	USD
CY2013	us-gaap	Depreciation And Amortization Discontinued Operations DepreciationAndAmortizationDiscontinuedOperations	2000	USD
CY2012	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	78764000	USD
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	93866000	USD
CY2011	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	74383000	USD
CY2013Q4	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	186351000	USD
CY2012Q4	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	0	USD
CY2012Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	1307000	USD
CY2013Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	186239000	USD
CY2013	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-3378000	USD
CY2011	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	USD
CY2012	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1307000	USD
CY2013Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	186239000	USD
CY2012Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1307000	USD
CY2011	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	922000	USD
CY2013	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	-9912000	USD
CY2012	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	-1238000	USD
CY2012Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	0	USD
CY2013Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	27092000	USD
CY2011	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.45
CY2012	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.21
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.16
CY2013Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.54
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.65
CY2012Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.39
CY2012Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2012Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.80
CY2012Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.55
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.13
CY2011	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.45
CY2012	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.21
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.64
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.16
CY2013Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.53
CY2012Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.39
CY2012Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.54
CY2012Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.80
CY2012Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
CY2013	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.448
CY2011	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.357
CY2012	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.450
CY2011	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2012	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.350
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Charitable Contributions EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions	0.006
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Charitable Contributions EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions	0.042
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Charitable Contributions EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions	0.016
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.000
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.062
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.096
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.033
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.007
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.003
CY2012	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.092
CY2011	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.009
CY2013	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.005
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	0.007
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	-0.037
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	-0.003
CY2013	us-gaap	Escrow Deposit Disbursements Related To Property Acquisition1 EscrowDepositDisbursementsRelatedToPropertyAcquisition1	332000	USD
CY2012	us-gaap	Escrow Deposit Disbursements Related To Property Acquisition1 EscrowDepositDisbursementsRelatedToPropertyAcquisition1	0	USD
CY2011	us-gaap	Escrow Deposit Disbursements Related To Property Acquisition1 EscrowDepositDisbursementsRelatedToPropertyAcquisition1	0	USD
CY2012	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	3667000	USD
CY2013	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	1674000	USD
CY2011	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	1651000	USD
CY2013	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	73000	USD
CY2012	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	526000	USD
CY2011	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	714000	USD
CY2013Q4	us-gaap	Fair Value Concentration Of Risk Investments FairValueConcentrationOfRiskInvestments	374000000	USD
CY2012Q4	us-gaap	Fair Value Concentration Of Risk Investments FairValueConcentrationOfRiskInvestments	428000000	USD
CY2011	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	81256000	USD
CY2012	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	0	USD
CY2013	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	121801000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	118361000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	139077000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	20400000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	12100000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	12400000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	12700000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	14700000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	237948000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	196072000	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	77711000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	98871000	USD
CY2011	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2013	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2012	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	1747000	USD
CY2012	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-2608000	USD
CY2013	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-1345000	USD
CY2011	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2011	us-gaap	Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee	0	USD
CY2012	us-gaap	Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee	1747000	USD
CY2013	us-gaap	Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee	0	USD
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	665996000	USD
CY2011	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	393452000	USD
CY2012	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	518615000	USD
CY2012Q4	us-gaap	Goodwill Goodwill	151088000	USD
CY2013Q4	us-gaap	Goodwill Goodwill	230738000	USD
CY2013	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2012	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2011	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	64575000	USD
CY2011Q4	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	64575000	USD
CY2013Q4	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	1595352000	USD
CY2013Q4	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue	58543000	USD
CY2013Q4	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount	58542000	USD
CY2013Q4	us-gaap	Goodwill Gross GoodwillGross	289268000	USD
CY2012Q4	us-gaap	Goodwill Gross GoodwillGross	209618000	USD
CY2012Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	58530000	USD
CY2013Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	58530000	USD
CY2011Q4	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	58500000	USD
CY2012	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2013	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2013	us-gaap	Goodwill Other Changes GoodwillOtherChanges	-79650000	USD
CY2013	us-gaap	Health Care Organization Health Care Costs Gross HealthCareOrganizationHealthCareCostsGross	5380124000	USD
CY2012	us-gaap	Health Care Organization Health Care Costs Gross HealthCareOrganizationHealthCareCostsGross	4991188000	USD
CY2011	us-gaap	Health Care Organization Health Care Costs Gross HealthCareOrganizationHealthCareCostsGross	3664161000	USD
CY2011	us-gaap	Health Care Organization Medical Supplies And Drugs Expense HealthCareOrganizationMedicalSuppliesAndDrugsExpense	418019000	USD
CY2012	us-gaap	Health Care Organization Medical Supplies And Drugs Expense HealthCareOrganizationMedicalSuppliesAndDrugsExpense	835830000	USD
CY2013	us-gaap	Health Care Organization Medical Supplies And Drugs Expense HealthCareOrganizationMedicalSuppliesAndDrugsExpense	935204000	USD
CY2011	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	8288000	USD
CY2012	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	18312000	USD
CY2013	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	26322000	USD
CY2011	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	4211493000	USD
CY2013	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	6179170000	USD
CY2012	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	5544121000	USD
CY2013Q1	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	1497433000	USD
CY2013Q2	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	1501729000	USD
CY2013Q3	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	1584656000	USD
CY2012Q4	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	1477384000	USD
CY2012Q1	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	1225363000	USD
CY2012Q2	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	1392774000	USD
CY2012Q3	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	1448600000	USD
CY2013Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	63093000	USD
CY2013Q4	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	4555000	USD
CY2013Q4	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount	4551000	USD
CY2013Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	63098000	USD
CY2011Q4	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	6100000	USD
CY2012	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2013Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-607000	USD
CY2013Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-85000	USD
CY2011	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	42914000	USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10513000	USD
CY2013	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2011	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	77388000	USD
CY2012	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	12866000	USD
CY2013	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	44830000	USD
CY2013Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	15796000	USD
CY2013Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-9041000	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	7553000	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	30522000	USD
CY2012Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	19894000	USD
CY2012Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	26194000	USD
CY2012Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-165000	USD
CY2012Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-33057000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	81146000	USD
CY2011	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	120302000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	23379000	USD
CY2011	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.69
CY2012	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.28
CY2013	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.98
CY2012	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.27
CY2011	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.67
CY2013	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.96
CY2012	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-3076000	USD
CY2011	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-56570000	USD
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	8099000	USD
CY2013Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	8775000	USD
CY2013Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	16000	USD
CY2012Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-1805000	USD
CY2012Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-4249000	USD
CY2012Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-551000	USD
CY2012Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	3529000	USD
CY2011	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-1.24
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.18
CY2012	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.07
CY2011	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-1.22
CY2012	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.06
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.17
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	36316000	USD
CY2013	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-19582000	USD
CY2011	us-gaap	Increase Decrease In Financial Instruments Used In Operating Activities IncreaseDecreaseInFinancialInstrumentsUsedInOperatingActivities	0	USD
CY2012	us-gaap	Increase Decrease In Financial Instruments Used In Operating Activities IncreaseDecreaseInFinancialInstrumentsUsedInOperatingActivities	-1307000	USD
CY2013	us-gaap	Increase Decrease In Financial Instruments Used In Operating Activities IncreaseDecreaseInFinancialInstrumentsUsedInOperatingActivities	-3378000	USD
CY2013	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	175257000	USD
CY2011	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	48120000	USD
CY2012	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	92054000	USD
CY2012	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	1913000	USD
CY2013	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	6899000	USD
CY2013	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	18992000	USD
CY2011	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	4064000	USD
CY2012	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	2647000	USD
CY2013	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	502000	shares
CY2011	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2012Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	0	USD
CY2013Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	32742000	USD
CY2013	us-gaap	Income Taxes Paid IncomeTaxesPaid	95240000	USD
CY2011	us-gaap	Income Taxes Paid IncomeTaxesPaid	54663000	USD
CY2012	us-gaap	Income Taxes Paid IncomeTaxesPaid	-4634000	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	60996000	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	23345000	USD
CY2011	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2778000	USD
CY2013	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-39262000	USD
CY2012	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	18172000	USD
CY2011	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-24855000	USD
CY2013	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	31047000	USD
CY2011	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-13836000	USD
CY2012	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	9887000	USD
CY2011	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-8154000	USD
CY2012	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	90851000	USD
CY2011	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	1898000	USD
CY2011	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3308000	USD
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	23064000	USD
CY2012	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	8958000	USD
CY2011	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-352000	USD
CY2012	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-18216000	USD
CY2013	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	149253000	USD
CY2012	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2011	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	669000	shares
CY2013	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	643000	shares
CY2012	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	619000	shares
CY2011	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	5446000	USD
CY2012	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	5075000	USD
CY2013	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	6890000	USD
CY2012	us-gaap	Interest Expense InterestExpense	16769000	USD
CY2011	us-gaap	Interest Expense InterestExpense	15519000	USD
CY2013	us-gaap	Interest Expense InterestExpense	52071000	USD
CY2011	us-gaap	Interest Expense Debt InterestExpenseDebt	12524000	USD
CY2012	us-gaap	Interest Expense Debt InterestExpenseDebt	12954000	USD
CY2013	us-gaap	Interest Expense Debt InterestExpenseDebt	34530000	USD
CY2011	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	7012000	USD
CY2012	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	7012000	USD
CY2013	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	12427000	USD
CY2012	us-gaap	Interest Paid InterestPaid	10099000	USD
CY2013	us-gaap	Interest Paid InterestPaid	34881000	USD
CY2011	us-gaap	Interest Paid InterestPaid	11399000	USD
CY2013	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	-11787000	USD
CY2012	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	-6746000	USD
CY2011	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	-7242000	USD
CY2012Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	10300000	USD
CY2012Q4	us-gaap	Liabilities Liabilities	1152508000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	2110000000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1934822000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3002937000	USD
CY2013	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0	USD
CY2011	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	-1045000	USD
CY2012	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	828037000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1293976000	USD
CY2013Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	669787000	USD
CY2012Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	494530000	USD
CY2010Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	354356000	USD
CY2011Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	402476000	USD
CY2012	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaid	4997702000	USD
CY2013	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaid	5317674000	USD
CY2011	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaid	3832504000	USD
CY2011	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear	3564030000	USD
CY2013	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear	4932195000	USD
CY2012	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear	4689395000	USD
CY2012	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears	308307000	USD
CY2013	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears	385479000	USD
CY2011	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears	268474000	USD
CY2011	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims	3859994000	USD
CY2012	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims	5096760000	USD
CY2013	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims	5381664000	USD
CY2012	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims Current Year LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsCurrentYear	5136055000	USD
CY2013	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims Current Year LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsCurrentYear	5434443000	USD
CY2011	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims Current Year LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsCurrentYear	3911803000	USD
CY2013	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims Prior Years LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYears	-52779000	USD
CY2012	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims Prior Years LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYears	-39295000	USD
CY2011	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims Prior Years LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYears	-51809000	USD
CY2012Q4	us-gaap	Line Of Credit Facility Amount Outstanding LineOfCreditFacilityAmountOutstanding	40000000	USD
CY2013Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	170000000	USD
CY2013Q4	us-gaap	Long Term Debt LongTermDebt	737000000	USD
CY2013Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	182008000	USD
CY2012Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1155000	USD
CY2013Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	550000000	USD
CY2013Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	187000000	USD
CY2013Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	USD
CY2013Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2013Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	49473000	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	47743000	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	493353000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-543311000	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-93584000	USD
CY2013Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2012Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	342845000	USD
CY2013Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	703052000	USD
CY2012Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	13419000	USD
CY2013Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	10898000	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-236927000	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	347784000	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	225395000	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	190083000	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	52929000	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	9790000	USD
CY2011	us-gaap	Net Income Loss NetIncomeLoss	20818000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	29915000	USD
CY2013Q4	us-gaap	Net Income Loss NetIncomeLoss	-9126000	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	24571000	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	7569000	USD
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	3364000	USD
CY2012Q4	us-gaap	Net Income Loss NetIncomeLoss	25643000	USD
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	-37306000	USD
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	18089000	USD
CY2013	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	41093000	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	136560000	USD
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	135821000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	586033000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	43512000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	32969000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	41473000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	399382000	USD
CY2011	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	23100000	USD
CY2012	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	20500000	USD
CY2013	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	24500000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	33930000	USD
CY2013Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	34767000	USD
CY2013Q4	us-gaap	Other Assets Current OtherAssetsCurrent	42484000	USD
CY2012Q4	us-gaap	Other Assets Current OtherAssetsCurrent	28386000	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	35564000	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	19621000	USD
CY2011	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	787000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	948000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-629000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	581000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-386000	USD
CY2011	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	380000	USD
CY2011	us-gaap	Other Expenses OtherExpenses	0	USD
CY2012	us-gaap	Other Expenses OtherExpenses	945000	USD
CY2013	us-gaap	Other Expenses OtherExpenses	3343000	USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	26351000	USD
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	23480000	USD
CY2012Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	86316000	USD
CY2013Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	0	USD
CY2011	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-15519000	USD
CY2013	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-55414000	USD
CY2012	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-17714000	USD
CY2013	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	149331000	USD
CY2012	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	0	USD
CY2011	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	0	USD
CY2013Q1	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	149331000	USD
CY2011	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	7000000	USD
CY2013	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	52662000	USD
CY2012	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3000000	USD
CY2013	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2012	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2011	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1125000	USD
CY2012	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2013	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	61521000	USD
CY2011	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	84253000	USD
CY2011	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	60581000	USD
CY2012	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	78145000	USD
CY2013	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	98049000	USD
CY2013	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	770083000	USD
CY2012	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	306437000	USD
CY2011	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	345968000	USD
CY2011	us-gaap	Payments To Acquire Projects PaymentsToAcquireProjects	42830000	USD
CY2012	us-gaap	Payments To Acquire Projects PaymentsToAcquireProjects	11610000	USD
CY2013	us-gaap	Payments To Acquire Projects PaymentsToAcquireProjects	-12638000	USD
CY2012	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	4991188000	USD
CY2011	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	3664161000	USD
CY2013	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	5380124000	USD
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
CY2012	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	9162000	USD
CY2011	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
CY2013	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	0	USD
CY2012	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	9162000	USD
CY2011	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	0	USD
CY2011	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2012	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2013	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	537973000	USD
CY2012	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	8205000	USD
CY2013	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	9402000	USD
CY2011	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	7347000	USD
CY2011	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
CY2012	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
CY2013	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	75074000	USD
CY2013Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	75074000	USD
CY2012	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	60000000	USD
CY2011	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2013	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2011	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	48600000	USD
CY2012	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	0	USD
CY2013	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	0	USD
CY2013	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	399595000	USD
CY2011	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	302667000	USD
CY2012	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	298006000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	392500000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	500017000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	292083000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	221443000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Owned Accumulated Depreciation PropertyPlantAndEquipmentOwnedAccumulatedDepreciation	84156000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Owned Accumulated Depreciation PropertyPlantAndEquipmentOwnedAccumulatedDepreciation	103918000	USD
CY2012	us-gaap	Sale Leaseback Transaction Gross Proceeds SaleLeasebackTransactionGrossProceeds	0	USD
CY2011	us-gaap	Sale Leaseback Transaction Gross Proceeds SaleLeasebackTransactionGrossProceeds	0	USD
CY2012	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	300000	USD
CY2011	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	400000	USD
CY2013	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	300000	USD
CY2012Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	149682000	USD
CY2013Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	298935000	USD
CY2013Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	40000000	USD
CY2013	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	47471000	USD
CY2012	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1129000	USD
CY2011	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2013	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	40000000	USD
CY2011	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	USD
CY2012	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	20000000	USD
CY2013Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	365200000	USD
CY2012Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	46900000	USD
CY2012Q4	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	44101000	USD
CY2013Q4	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	63093000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	500200000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	553129000	USD
CY2012	us-gaap	Revenues Revenues	5914209000	USD
CY2013	us-gaap	Revenues Revenues	6588934000	USD
CY2011	us-gaap	Revenues Revenues	4540263000	USD
CY2013	us-gaap	Sale Leaseback Transaction Gross Proceeds SaleLeasebackTransactionGrossProceeds	158694000	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	28694000	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	20018000	USD
CY2011	us-gaap	Share Based Compensation ShareBasedCompensation	17052000	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	324221	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	22.58
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	300	shares
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	45000	shares
CY2011	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	13.97
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	14.67
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4024000	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	379221	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	414061	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	24.14
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	22.39
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	4024000	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	379221	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	24.14
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	20.09
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	17.63
CY2013	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	33.02
CY2013Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	324221	shares
CY2013Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	379221	shares
CY2013Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	3947000	USD
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y6M
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y5M
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P3Y5M
CY2012Q4	us-gaap	Shares Outstanding SharesOutstanding	46762000	shares
CY2011Q4	us-gaap	Shares Outstanding SharesOutstanding	45815000	shares
CY2010Q4	us-gaap	Shares Outstanding SharesOutstanding	45463000	shares
CY2013Q4	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Estimated Range Of Change Upper Bound SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleEstimatedRangeOfChangeUpperBound	6200000	USD
CY2013Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	662000000	USD
CY2013Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Required StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired	389000000.0	USD
CY2013	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	299600	shares
CY2011	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	201700	shares
CY2012	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	277400	shares
CY2012	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	1057000	shares
CY2013	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	820000	shares
CY2013	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	79540	shares
CY2012	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	16362000	USD
CY2011	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	20474000	USD
CY2013	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	30386000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	782314000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	892937000	USD
CY2011Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	755073000	USD
CY2012Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	782314000	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	892937000	USD
CY2010Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	719057000	USD
CY2013	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	110600000	USD
CY2012	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	0	USD
CY2011	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	1952000	USD
CY2013	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	0	USD
CY2013Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	10800000	USD
CY2011	us-gaap	Technology Services Costs TechnologyServicesCosts	143987000	USD
CY2013	us-gaap	Technology Services Costs TechnologyServicesCosts	161494000	USD
CY2012	us-gaap	Technology Services Costs TechnologyServicesCosts	141208000	USD
CY2013	us-gaap	Technology Services Revenue TechnologyServicesRevenue	204535000	USD
CY2012	us-gaap	Technology Services Revenue TechnologyServicesRevenue	187710000	USD
CY2011	us-gaap	Technology Services Revenue TechnologyServicesRevenue	160447000	USD
CY2013Q3	us-gaap	Technology Services Revenue TechnologyServicesRevenue	51100000	USD
CY2013Q4	us-gaap	Technology Services Revenue TechnologyServicesRevenue	54007000	USD
CY2013Q1	us-gaap	Technology Services Revenue TechnologyServicesRevenue	49756000	USD
CY2013Q2	us-gaap	Technology Services Revenue TechnologyServicesRevenue	49672000	USD
CY2012Q4	us-gaap	Technology Services Revenue TechnologyServicesRevenue	55359000	USD
CY2012Q1	us-gaap	Technology Services Revenue TechnologyServicesRevenue	42205000	USD
CY2012Q2	us-gaap	Technology Services Revenue TechnologyServicesRevenue	41724000	USD
CY2012Q3	us-gaap	Technology Services Revenue TechnologyServicesRevenue	48422000	USD
CY2013	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount	0	USD
CY2011	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount	0	USD
CY2012Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	111000	shares
CY2012Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3000000	USD
CY2013Q4	us-gaap	Treasury Stock Value TreasuryStockValue	0	USD
CY2013	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	52662000	USD
CY2012	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	3000000	USD
CY2011	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	7000000	USD
CY2012	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1529000	USD
CY2011	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1167000	USD
CY2013	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-1015000	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10622000	USD
CY2010Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10962000	USD
CY2011Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10712000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	8030000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	886000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2011	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2011	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2013	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	3615000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	320000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	79000	USD
CY2011Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	65000	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	56000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	2084000	USD
CY2011	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2012	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2011	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	137000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	441000	USD
CY2011	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	387000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	175000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	211000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits Resulting In Net Operating Loss Carryforward UnrecognizedTaxBenefitsResultingInNetOperatingLossCarryforward	3600000	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	7400000	USD
CY2011Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	7400000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	5700000	USD
CY2013	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements. Estimates also affect the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Principal areas requiring the use of estimates include:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Health plan contractual provisions that may limit revenue based upon the costs incurred or the profits realized under a specific contract;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Health plan quality incentives that allow us to recognize incremental revenue if certain quality standards are met;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The determination of medical claims and benefits payable of our Health Plans segment;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The valuation of certain investments;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Settlements under risk or savings sharing programs;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The assessment of deferred contract costs, deferred revenue, long-lived and intangible assets, and goodwill for impairment;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The determination of professional and general liability claims, and reserves for potential absorption of claims unpaid by insolvent providers;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The determination of reserves for the outcome of litigation;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The determination of valuation allowances for deferred tax assets; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The determination of unrecognized tax benefits.</font></div></td></tr></table></div>
CY2013	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	600000	USD
CY2012	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46999000	shares
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46862000	shares
CY2011	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46425000	shares
CY2011	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	160000	shares
CY2012	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	2000	shares
CY2013	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	1445000	shares
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45717000	shares
CY2012	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46380000	shares
CY2011	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45756000	shares
CY2012	moh	Amortizationof Debt Discount Premiumand Sale Leaseback Financing Obligation AmortizationofDebtDiscountPremiumandSaleLeasebackFinancingObligation	5942000	USD
CY2013	moh	Amortizationof Debt Discount Premiumand Sale Leaseback Financing Obligation AmortizationofDebtDiscountPremiumandSaleLeasebackFinancingObligation	22820000	USD
CY2011	moh	Amortizationof Debt Discount Premiumand Sale Leaseback Financing Obligation AmortizationofDebtDiscountPremiumandSaleLeasebackFinancingObligation	5512000	USD
CY2012Q4	moh	Anticipated Medicare Risk Adjustment Premiums AnticipatedMedicareRiskAdjustmentPremiums	300000	USD
CY2013Q4	moh	Anticipated Medicare Risk Adjustment Premiums AnticipatedMedicareRiskAdjustmentPremiums	20800000	USD
CY2012Q4	moh	Available For Sale Securities Gross Unrealized Gain Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments	809000	USD
CY2013Q4	moh	Available For Sale Securities Gross Unrealized Gain Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments	613000	USD
CY2012Q4	moh	Availableforsale Securities Continuous Unrealized Loss Position12 Monthsor Longer Aggregate Loss Accumulatedin Investments AvailableforsaleSecuritiesContinuousUnrealizedLossPosition12MonthsorLongerAggregateLossAccumulatedinInvestments	1231000	USD
CY2013Q4	moh	Availableforsale Securities Continuous Unrealized Loss Position12 Monthsor Longer Aggregate Loss Accumulatedin Investments AvailableforsaleSecuritiesContinuousUnrealizedLossPosition12MonthsorLongerAggregateLossAccumulatedinInvestments	1049000	USD
CY2012	moh	Availableforsale Securities Continuous Unrealized Loss Position12 Monthsor Longer Numberof Securities AvailableforsaleSecuritiesContinuousUnrealizedLossPosition12MonthsorLongerNumberofSecurities	21	Security
CY2013	moh	Availableforsale Securities Continuous Unrealized Loss Position12 Monthsor Longer Numberof Securities AvailableforsaleSecuritiesContinuousUnrealizedLossPosition12MonthsorLongerNumberofSecurities	57
CY2012Q4	moh	Availableforsale Securities Continuous Unrealized Loss Position Lessthan12 Months Aggregate Loss Accumulatedin Investments AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessthan12MonthsAggregateLossAccumulatedinInvestments	314000	USD
CY2013Q4	moh	Availableforsale Securities Continuous Unrealized Loss Position Lessthan12 Months Aggregate Loss Accumulatedin Investments AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessthan12MonthsAggregateLossAccumulatedinInvestments	1316000	USD
CY2012	moh	Availableforsale Securities Continuous Unrealized Loss Position Lessthan12 Months Numberof Securities AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessthan12MonthsNumberofSecurities	72	Security
CY2013	moh	Availableforsale Securities Continuous Unrealized Loss Position Lessthan12 Months Numberof Securities AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessthan12MonthsNumberofSecurities	174
CY2012Q4	moh	Availableforsale Securities Gross Unrealized Loss Accumulated In Investments AvailableforsaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments	1545000	USD
CY2013Q4	moh	Availableforsale Securities Gross Unrealized Loss Accumulated In Investments AvailableforsaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments	2365000	USD
CY2012	moh	Business Combination Contingent Consideration Accrual BusinessCombinationContingentConsiderationAccrual	0	USD
CY2013	moh	Business Combination Contingent Consideration Accrual BusinessCombinationContingentConsiderationAccrual	59948000	USD
CY2011	moh	Business Combination Contingent Consideration Accrual BusinessCombinationContingentConsiderationAccrual	0	USD
CY2013Q1	moh	Call Spread Cash Paid CallSpreadCashPaid	74200000	USD
CY2013Q1	moh	Class Of Warrant Or Right Threshold Percentage Of Stock Price Trigger ClassOfWarrantOrRightThresholdPercentageOfStockPriceTrigger	0.00625
CY2013Q1	moh	Class Of Warrant Or Right Trading Days Measurement Period ClassOfWarrantOrRightTradingDaysMeasurementPeriod	P160D
CY2013	moh	Class Of Warrant Or Right Trading Days Measurement Period ClassOfWarrantOrRightTradingDaysMeasurementPeriod	P160D
CY2013Q4	moh	Classof Warrantor Right Stated Percentage ClassofWarrantorRightStatedPercentage	0.01125
CY2012	moh	Cost Of Services Amortization Of Capitalized Software CostOfServicesAmortizationOfCapitalizedSoftware	13489000	USD
CY2011	moh	Cost Of Services Amortization Of Capitalized Software CostOfServicesAmortizationOfCapitalizedSoftware	16871000	USD
CY2013	moh	Cost Of Services Amortization Of Capitalized Software CostOfServicesAmortizationOfCapitalizedSoftware	18207000	USD
CY2013	moh	Deferred Compensation Plan Deferral Percentage Of Basic Salary DeferredCompensationPlanDeferralPercentageOfBasicSalary	1
CY2013	moh	Deferred Compensation Plan Deferral Percentage Of Bonus DeferredCompensationPlanDeferralPercentageOfBonus	1
CY2012Q4	moh	Deferred Tax Assets Financing Arrangements DeferredTaxAssetsFinancingArrangements	0	USD
CY2013Q4	moh	Deferred Tax Assets Financing Arrangements DeferredTaxAssetsFinancingArrangements	-2162000	USD
CY2012Q4	moh	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Prepaid Expenses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPrepaidExpenses	-4390000	USD
CY2013Q4	moh	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Prepaid Expenses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPrepaidExpenses	-5354000	USD
CY2013Q4	moh	Deferred Tax Liabilities Deferred Compensation DeferredTaxLiabilitiesDeferredCompensation	-3404000	USD
CY2012Q4	moh	Deferred Tax Liabilities Deferred Compensation DeferredTaxLiabilitiesDeferredCompensation	-3323000	USD
CY2013Q4	moh	Deferred Tax Liabilities Operating Losses DeferredTaxLiabilitiesOperatingLosses	-2326000	USD
CY2012Q4	moh	Deferred Tax Liabilities Operating Losses DeferredTaxLiabilitiesOperatingLosses	-3341000	USD
CY2013Q4	moh	Deferred Tax Liabilities Reserve Liabilities DeferredTaxLiabilitiesReserveLiabilities	-1909000	USD
CY2012Q4	moh	Deferred Tax Liabilities Reserve Liabilities DeferredTaxLiabilitiesReserveLiabilities	-2013000	USD
CY2013Q4	moh	Deferred Tax Liabilities State Taxes DeferredTaxLiabilitiesStateTaxes	-7027000	USD
CY2012Q4	moh	Deferred Tax Liabilities State Taxes DeferredTaxLiabilitiesStateTaxes	-4149000	USD
CY2012Q4	moh	Deferred Tax Liabilities Unrealized Losses DeferredTaxLiabilitiesUnrealizedLosses	-563000	USD
CY2013Q4	moh	Deferred Tax Liabilities Unrealized Losses DeferredTaxLiabilitiesUnrealizedLosses	-286000	USD
CY2013	moh	Denominator For Basic Earnings Per Share DenominatorForBasicEarningsPerShare	45717000	shares
CY2012	moh	Denominator For Basic Earnings Per Share DenominatorForBasicEarningsPerShare	46380000	shares
CY2011	moh	Denominator For Basic Earnings Per Share DenominatorForBasicEarningsPerShare	45756000	shares
CY2013	moh	Denominator For Diluted Earnings Per Share DenominatorForDilutedEarningsPerShare	46862000	shares
CY2012	moh	Denominator For Diluted Earnings Per Share DenominatorForDilutedEarningsPerShare	46999000	shares
CY2011	moh	Denominator For Diluted Earnings Per Share DenominatorForDilutedEarningsPerShare	46425000	shares
CY2012	moh	Depreciation And Amortization Of Capitalized Software DepreciationAndAmortizationOfCapitalizedSoftware	42938000	USD
CY2011	moh	Depreciation And Amortization Of Capitalized Software DepreciationAndAmortizationOfCapitalizedSoftware	30803000	USD
CY2013	moh	Depreciation And Amortization Of Capitalized Software DepreciationAndAmortizationOfCapitalizedSoftware	54837000	USD
CY2012	moh	Depreciationand Amortization Continuing Operations DepreciationandAmortizationContinuingOperations	63114000	USD
CY2013	moh	Depreciationand Amortization Continuing Operations DepreciationandAmortizationContinuingOperations	72743000	USD
CY2011	moh	Depreciationand Amortization Continuing Operations DepreciationandAmortizationContinuingOperations	48253000	USD
CY2013Q1	moh	Derivative Cost Of Hedge Cash Paid For Premium DerivativeCostOfHedgeCashPaidForPremium	149300000	USD
CY2013Q2	moh	Derivative Settlement Amount DerivativeSettlementAmount	900000	USD
CY2013	moh	Divestiture Of Business Decrease In Carrying Value Of Assets DivestitureOfBusinessDecreaseInCarryingValueOfAssets	0	USD
CY2012	moh	Divestiture Of Business Decrease In Carrying Value Of Assets DivestitureOfBusinessDecreaseInCarryingValueOfAssets	30942000	USD
CY2011	moh	Divestiture Of Business Decrease In Carrying Value Of Assets DivestitureOfBusinessDecreaseInCarryingValueOfAssets	0	USD
CY2013	moh	Divestiture Of Business Decrease In Carrying Value Of Liabilities DivestitureOfBusinessDecreaseInCarryingValueOfLiabilities	0	USD
CY2011	moh	Divestiture Of Business Decrease In Carrying Value Of Liabilities DivestitureOfBusinessDecreaseInCarryingValueOfLiabilities	0	USD
CY2012	moh	Divestiture Of Business Decrease In Carrying Value Of Liabilities DivestitureOfBusinessDecreaseInCarryingValueOfLiabilities	23527000	USD
CY2011	moh	Effective Income Tax Rate Reconciliation Nondeductible Expense Warrants Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseWarrantsPercent	0.000
CY2012	moh	Effective Income Tax Rate Reconciliation Nondeductible Expense Warrants Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseWarrantsPercent	0.000
CY2013	moh	Effective Income Tax Rate Reconciliation Nondeductible Expense Warrants Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseWarrantsPercent	0.024
CY2013	moh	Effective Income Tax Rate Reconciliation Purchase Accounting Adjustment Percent EffectiveIncomeTaxRateReconciliationPurchaseAccountingAdjustmentPercent	0.000
CY2012	moh	Effective Income Tax Rate Reconciliation Purchase Accounting Adjustment Percent EffectiveIncomeTaxRateReconciliationPurchaseAccountingAdjustmentPercent	0.000
CY2011	moh	Effective Income Tax Rate Reconciliation Purchase Accounting Adjustment Percent EffectiveIncomeTaxRateReconciliationPurchaseAccountingAdjustmentPercent	-0.008
CY2011	moh	Effective Income Tax Reconciliation Change In Fair Value Of Contingent Consideration EffectiveIncomeTaxReconciliationChangeInFairValueOfContingentConsideration	0.000
CY2012	moh	Effective Income Tax Reconciliation Change In Fair Value Of Contingent Consideration EffectiveIncomeTaxReconciliationChangeInFairValueOfContingentConsideration	0.048
CY2013	moh	Effective Income Tax Reconciliation Change In Fair Value Of Contingent Consideration EffectiveIncomeTaxReconciliationChangeInFairValueOfContingentConsideration	-0.003
CY2011Q4	moh	Goodwill And Intangible Assets Net GoodwillAndIntangibleAssetsNet	255750000	USD
CY2012Q4	moh	Goodwill And Intangible Assets Net GoodwillAndIntangibleAssetsNet	228799000	USD
CY2013Q4	moh	Goodwill And Intangible Assets Net GoodwillAndIntangibleAssetsNet	329609000	USD
CY2011	moh	Health Care Organization Direct Delivery Expense HealthCareOrganizationDirectDeliveryExpense	29683000	USD
CY2013	moh	Health Care Organization Direct Delivery Expense HealthCareOrganizationDirectDeliveryExpense	48288000	USD
CY2012	moh	Health Care Organization Direct Delivery Expense HealthCareOrganizationDirectDeliveryExpense	33920000	USD
CY2013	moh	Health Care Organization Direct Delivery Expense Per Member Per Month HealthCareOrganizationDirectDeliveryExpensePerMemberPerMonth	2.14
CY2012	moh	Health Care Organization Direct Delivery Expense Per Member Per Month HealthCareOrganizationDirectDeliveryExpensePerMemberPerMonth	1.60
CY2011	moh	Health Care Organization Direct Delivery Expense Per Member Per Month HealthCareOrganizationDirectDeliveryExpensePerMemberPerMonth	1.57
CY2013	moh	Health Care Organization Estimated Assessment Fees HealthCareOrganizationEstimatedAssessmentFees	85000000	USD
CY2012	moh	Health Care Organization Expenses Capitation Costs HealthCareOrganizationExpensesCapitationCosts	552136000	USD
CY2013	moh	Health Care Organization Expenses Capitation Costs HealthCareOrganizationExpensesCapitationCosts	603938000	USD
CY2011	moh	Health Care Organization Expenses Capitation Costs HealthCareOrganizationExpensesCapitationCosts	505892000	USD
CY2013	moh	Health Care Organization Expenses Capitation Costs Per Member Per Month HealthCareOrganizationExpensesCapitationCostsPerMemberPerMonth	26.83
CY2012	moh	Health Care Organization Expenses Capitation Costs Per Member Per Month HealthCareOrganizationExpensesCapitationCostsPerMemberPerMonth	26.07
CY2011	moh	Health Care Organization Expenses Capitation Costs Per Member Per Month HealthCareOrganizationExpensesCapitationCostsPerMemberPerMonth	26.73
CY2011	moh	Health Care Organization Expenses Gross Per Member Per Month HealthCareOrganizationExpensesGrossPerMemberPerMonth	193.62
CY2012	moh	Health Care Organization Expenses Gross Per Member Per Month HealthCareOrganizationExpensesGrossPerMemberPerMonth	235.68
CY2013	moh	Health Care Organization Expenses Gross Per Member Per Month HealthCareOrganizationExpensesGrossPerMemberPerMonth	238.99
CY2013	moh	Health Care Organization Expenses Other Costs HealthCareOrganizationExpensesOtherCosts	181165000	USD
CY2012	moh	Health Care Organization Expenses Other Costs HealthCareOrganizationExpensesOtherCosts	145551000	USD
CY2011	moh	Health Care Organization Expenses Other Costs HealthCareOrganizationExpensesOtherCosts	123187000	USD
CY2011	moh	Health Care Organization Expenses Other Costs Per Member Per Month HealthCareOrganizationExpensesOtherCostsPerMemberPerMonth	6.51
CY2012	moh	Health Care Organization Expenses Other Costs Per Member Per Month HealthCareOrganizationExpensesOtherCostsPerMemberPerMonth	6.87
CY2013	moh	Health Care Organization Expenses Other Costs Per Member Per Month HealthCareOrganizationExpensesOtherCostsPerMemberPerMonth	8.05
CY2012	moh	Health Care Organization Expenses Servicing Cost HealthCareOrganizationExpensesServicingCost	3423751000	USD
CY2013	moh	Health Care Organization Expenses Servicing Cost HealthCareOrganizationExpensesServicingCost	3611529000	USD
CY2011	moh	Health Care Organization Expenses Servicing Cost HealthCareOrganizationExpensesServicingCost	2587380000	USD
CY2011	moh	Health Care Organization Expenses Servicing Cost Per Member Per Month HealthCareOrganizationExpensesServicingCostPerMemberPerMonth	136.72
CY2013	moh	Health Care Organization Expenses Servicing Cost Per Member Per Month HealthCareOrganizationExpensesServicingCostPerMemberPerMonth	160.43
CY2012	moh	Health Care Organization Expenses Servicing Cost Per Member Per Month HealthCareOrganizationExpensesServicingCostPerMemberPerMonth	161.67
CY2013	moh	Health Care Organization Medical Suppliesand Drugs Expense Per Member Per Month HealthCareOrganizationMedicalSuppliesandDrugsExpensePerMemberPerMonth	41.54
CY2011	moh	Health Care Organization Medical Suppliesand Drugs Expense Per Member Per Month HealthCareOrganizationMedicalSuppliesandDrugsExpensePerMemberPerMonth	22.09
CY2012	moh	Health Care Organization Medical Suppliesand Drugs Expense Per Member Per Month HealthCareOrganizationMedicalSuppliesandDrugsExpensePerMemberPerMonth	39.47
CY2011	moh	Health Care Organization Premium Tax Revenue HealthCareOrganizationPremiumTaxRevenue	154589000	USD
CY2012	moh	Health Care Organization Premium Tax Revenue HealthCareOrganizationPremiumTaxRevenue	158991000	USD
CY2013	moh	Health Care Organization Premium Tax Revenue HealthCareOrganizationPremiumTaxRevenue	172017000	USD
CY2013Q4	moh	Health Plans In Number Of States HealthPlansInNumberOfStates	11	State
CY2013	moh	Maturity Of Cash And Cash Equivalents MaturityOfCashAndCashEquivalents	three months or less
CY2013	moh	Maximum Period For Member Risk Scores And Member Pharmacy Cost Experience After Original Year Of Service MaximumPeriodForMemberRiskScoresAndMemberPharmacyCostExperienceAfterOriginalYearOfService	P2Y
CY2011	moh	Medical Administrative Costs MedicalAdministrativeCosts	99300000	USD
CY2012	moh	Medical Administrative Costs MedicalAdministrativeCosts	125200000	USD
CY2013	moh	Medical Administrative Costs MedicalAdministrativeCosts	153000000	USD
CY2013Q4	moh	Medical Claimsand Benefits Payable MedicalClaimsandBenefitsPayable	151300000	USD
CY2012	moh	Medical Claimsand Benefits Payable Adjustments Changein Provider MedicalClaimsandBenefitsPayableAdjustmentsChangeinProvider	-7004000	USD
CY2013	moh	Medical Claimsand Benefits Payable Adjustments Changein Provider MedicalClaimsandBenefitsPayableAdjustmentsChangeinProvider	111267000	USD
CY2011	moh	Medical Claimsand Benefits Payable Adjustments Changein Provider MedicalClaimsandBenefitsPayableAdjustmentsChangeinProvider	20630000	USD
CY2013Q1	moh	Minimum Operating Revenue For Vesting Of Awards MinimumOperatingRevenueForVestingOfAwards	12000000000	USD
CY2012Q4	moh	Numberof Lettersof Credit Outstanding NumberofLettersofCreditOutstanding	2	letters_of_credit
CY2011	moh	Premium Tax Expenses PremiumTaxExpenses	154589000	USD
CY2011	moh	Policy Holder Medical Care Cost Prior Year Percentage PolicyHolderMedicalCareCostPriorYearPercentage	0.013
CY2012	moh	Policy Holder Premium Revenue Prior Year Percentage PolicyHolderPremiumRevenuePriorYearPercentage	0.007
CY2013	moh	Policy Holder Premium Revenue Prior Year Percentage PolicyHolderPremiumRevenuePriorYearPercentage	0.009
CY2011	moh	Policy Holder Premium Revenue Prior Year Percentage PolicyHolderPremiumRevenuePriorYearPercentage	0.012
CY2012	moh	Percentage Of Capitation PercentageOfCapitation	0.111
CY2011	moh	Percentage Of Capitation PercentageOfCapitation	0.138
CY2013	moh	Percentage Of Capitation PercentageOfCapitation	0.112
CY2013	moh	Percentage Of Fee For Service PercentageOfFeeForService	0.671
CY2011	moh	Percentage Of Fee For Service PercentageOfFeeForService	0.706
CY2012	moh	Percentage Of Fee For Service PercentageOfFeeForService	0.686
CY2013Q1	moh	Percentage Of Financial Responsibility Ceded PercentageOfFinancialResponsibilityCeded	1.00
CY2012	moh	Percentage Of Medical Costs PercentageOfMedicalCosts	1
CY2013	moh	Percentage Of Medical Costs PercentageOfMedicalCosts	1
CY2011	moh	Percentage Of Medical Costs PercentageOfMedicalCosts	1
CY2011	moh	Percentage Of Other PercentageOfOther	0.034
CY2013	moh	Percentage Of Other PercentageOfOther	0.034
CY2012	moh	Percentage Of Other PercentageOfOther	0.029
CY2013	moh	Percentage Of Pharmacy PercentageOfPharmacy	0.174
CY2012	moh	Percentage Of Pharmacy PercentageOfPharmacy	0.167
CY2011	moh	Percentage Of Pharmacy PercentageOfPharmacy	0.114
CY2013	moh	Percentage Of Premium Recorded As Fixed Amount Per Member Per Month PercentageOfPremiumRecordedAsFixedAmountPerMemberPerMonth	0.97
CY2013	moh	Percentage Of Premium Revenue In Form Of Birth Income PercentageOfPremiumRevenueInFormOfBirthIncome	0.03
CY2013	moh	Percentof Direct Delivery PercentofDirectDelivery	0.009
CY2012	moh	Percentof Direct Delivery PercentofDirectDelivery	0.007
CY2011	moh	Percentof Direct Delivery PercentofDirectDelivery	0.008
CY2012	moh	Policy Holder Benefits Prior Percentage PolicyHolderBenefitsPriorPercentage	0.098
CY2013	moh	Policy Holder Benefits Prior Percentage PolicyHolderBenefitsPriorPercentage	0.107
CY2011	moh	Policy Holder Benefits Prior Percentage PolicyHolderBenefitsPriorPercentage	0.146
CY2012	moh	Policy Holder Medical Care Cost Prior Year Percentage PolicyHolderMedicalCareCostPriorYearPercentage	0.008
CY2013	moh	Policy Holder Medical Care Cost Prior Year Percentage PolicyHolderMedicalCareCostPriorYearPercentage	0.010
CY2013	moh	Premium Tax Expenses PremiumTaxExpenses	172017000	USD
CY2012	moh	Premium Tax Expenses PremiumTaxExpenses	158991000	USD
CY2013	moh	Retirement Of Common Stock Used For Stock Based Compensation RetirementOfCommonStockUsedForStockBasedCompensation	7711000	USD
CY2012	moh	Retirement Of Common Stock Used For Stock Based Compensation RetirementOfCommonStockUsedForStockBasedCompensation	11862000	USD
CY2011	moh	Retirement Of Common Stock Used For Stock Based Compensation RetirementOfCommonStockUsedForStockBasedCompensation	3926000	USD
CY2011	moh	Retirement Of Treasury Stock RetirementOfTreasuryStock	7000000	USD
CY2013	moh	Retirement Of Treasury Stock RetirementOfTreasuryStock	55662000	USD
CY2012	moh	Retirement Of Treasury Stock RetirementOfTreasuryStock	0	USD
CY2013Q4	moh	Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Plans SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPlans	2	Plan
CY2013	moh	Weighted Average Number Of Shares Issued Under Equity Offering WeightedAverageNumberOfSharesIssuedUnderEquityOffering	400000	shares
CY2012	moh	Weighted Average Number Of Shares Issued Under Equity Offering WeightedAverageNumberOfSharesIssuedUnderEquityOffering	567000	shares
CY2011	moh	Weighted Average Number Of Shares Issued Under Equity Offering WeightedAverageNumberOfSharesIssuedUnderEquityOffering	453000	shares
CY2013	dei	Amendment Flag AmendmentFlag	false
CY2013	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2013	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013	dei	Document Period End Date DocumentPeriodEndDate	2013-12-31
CY2013	dei	Document Type DocumentType	10-K
CY2013	dei	Entity Central Index Key EntityCentralIndexKey	0001179929
CY2014Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	45977000	shares
CY2013	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2013	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2013Q2	dei	Entity Public Float EntityPublicFloat	1060900000	USD
CY2013	dei	Entity Registrant Name EntityRegistrantName	MOLINA HEALTHCARE INC
CY2013	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2013	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes

Files In Submission

Name	View Source	Status
0001179929-14-000004-index-headers.html	Edgar Link	pending
0001179929-14-000004-index.html	Edgar Link	pending
0001179929-14-000004.txt	Edgar Link	pending
0001179929-14-000004-xbrl.zip	Edgar Link	pending
amolinagraph.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
moh-12312013x10k.htm	Edgar Link	pending
moh-12312013x10kex105.htm	Edgar Link	pending
moh-12312013x10kex106.htm	Edgar Link	pending
moh-12312013x10kex108.htm	Edgar Link	pending
moh-12312013x10kex109.htm	Edgar Link	pending
moh-12312013x10kex121.htm	Edgar Link	pending
moh-12312013x10kex211.htm	Edgar Link	pending
moh-12312013x10kex231.htm	Edgar Link	pending
moh-12312013x10kex311.htm	Edgar Link	pending
moh-12312013x10kex312.htm	Edgar Link	pending
moh-12312013x10kex321.htm	Edgar Link	pending
moh-12312013x10kex322.htm	Edgar Link	pending
moh-20131231.xml	Edgar Link	completed
moh-20131231.xsd	Edgar Link	pending
moh-20131231_cal.xml	Edgar Link	unprocessable
moh-20131231_def.xml	Edgar Link	unprocessable
moh-20131231_lab.xml	Edgar Link	unprocessable
moh-20131231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MOH
MOLINA HEALTHCARE, INC. Stock $moh

2013 Q4 Form 10-K Financial Statement

#000117992914000004 Filed on February 26, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOH MOLINA HEALTHCARE, INC. Stock $moh

2013 Q4 Form 10-K Financial Statement

#000117992914000004 Filed on February 26, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOH
MOLINA HEALTHCARE, INC. Stock $moh